Assessment of decompensation in patients with cirrhosis based on gadoxetic acid enhanced MR imaging parameters

Motivation: It is important to identify patients with cirrhosis at high risk of decompensation or death using noninvasive methods to stabilize disease progression and reduce patient mortalityGoal(s): To investigate whether the functional parameters from gadoxetic acid–enhanced MRI can predict decompensation in cirrhosis. Approach: To compare MRI parameters and clinical parameters between CACLD and DACLD groups. Associations between MRI parameters and clinical parameters were investigated. To differentiate the diagnostic performance of MRI parameters and clinical parameters between CACLD and DACLD groups. Results: The functional parameters from gadoxetic acid–enhanced MRI can predict decompensation in cirrhosis. Impact: This study confirms that non-invasive imaging parameters can predict the decompensation of cirrhosis and provides a new method for clinicians to evaluate the condition of patients with cirrhosis.